...BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023
Presentation Title: A model to predict the risk of prolonged thrombocytopenia recovery in relapsed/refractory multiple myeloma patients after anti-BCMA CAR-T treatment Conference Session Title: Treatment of Relapsed/Refractory Multiple Myelo...